BCAX Collar Strategy
BCAX (Bicara Therapeutics Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.
BCAX (Bicara Therapeutics Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.15B, a beta of -0.56 versus the broader market, a 52-week range of 7.8-24.25, average daily share volume of 578K, a public-listing history dating back to 2024, approximately 55 full-time employees. These structural characteristics shape how BCAX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.56 indicates BCAX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on BCAX?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current BCAX snapshot
As of May 15, 2026, spot at $20.13, ATM IV 66.10%, IV rank 11.16%, expected move 18.95%. The collar on BCAX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on BCAX specifically: IV regime affects collar pricing on both sides; compressed BCAX IV at 66.10% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 18.95% (roughly $3.81 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BCAX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BCAX should anchor to the underlying notional of $20.13 per share and to the trader's directional view on BCAX stock.
BCAX collar setup
The BCAX collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BCAX near $20.13, the first option leg uses a $21.14 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BCAX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BCAX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $20.13 | long |
| Sell 1 | Call | $21.14 | N/A |
| Buy 1 | Put | $19.12 | N/A |
BCAX collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
BCAX collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on BCAX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on BCAX
Collars on BCAX hedge an existing long BCAX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
BCAX thesis for this collar
The market-implied 1-standard-deviation range for BCAX extends from approximately $16.32 on the downside to $23.94 on the upside. A BCAX collar hedges an existing long BCAX position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current BCAX IV rank near 11.16% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BCAX at 66.10%. As a Healthcare name, BCAX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BCAX-specific events.
BCAX collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BCAX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BCAX alongside the broader basket even when BCAX-specific fundamentals are unchanged. Always rebuild the position from current BCAX chain quotes before placing a trade.
Frequently asked questions
- What is a collar on BCAX?
- A collar on BCAX is the collar strategy applied to BCAX (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With BCAX stock trading near $20.13, the strikes shown on this page are snapped to the nearest listed BCAX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BCAX collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the BCAX collar priced from the end-of-day chain at a 30-day expiry (ATM IV 66.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BCAX collar?
- The breakeven for the BCAX collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BCAX market-implied 1-standard-deviation expected move is approximately 18.95%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on BCAX?
- Collars on BCAX hedge an existing long BCAX stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current BCAX implied volatility affect this collar?
- BCAX ATM IV is at 66.10% with IV rank near 11.16%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.